XML 20 R57.htm IDEA: XBRL DOCUMENT v2.4.0.6
Guarantor Non-Guarantor Subsidiary Financial Information Level 4 (Details) - Consolidating Statement of Cash Flows (USD $)
In Millions, unless otherwise specified
9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Net cash provided by (used in) operating activities $ 27 $ (28)
Cash flows provided by (used in) investing activities    
Capital expenditures (92) (109)
Proceeds from the sale of (purchases of) debt securities, net 2 (3)
Change in restricted cash 0 3
Funds remitted to unconsolidated affiliates (1) (5)
Proceeds from sale of assets 10 3
Proceeds from sale of business, net of cash transferred 0 173
Net cash (used in) provided by investing activities (81) 62
Cash flows (used in) provided by financing activities    
Net short-term debt (repayments) borrowings (7) 11
Borrowings of long-term debt 451 455
Repayments of long-term debt (479) (507)
Repayment of advance from affiliates (7) 0
Capital contribution from parent 16 0
Long-term debt and credit facility financing fees (13) (1)
Common stock dividends paid (2) (1)
Net cash used in financing activities (41) (43)
Effect of exchange rates on cash and cash equivalents 4 (3)
Decrease in cash and cash equivalents (91) (12)
Cash and cash equivalents (unrestricted) at beginning of period 428 180
Cash and cash equivalents (unrestricted) at end of period 337 168
Momentive Specialty Chemicals Inc. [Member]
   
Net cash provided by (used in) operating activities 2 (96)
Cash flows provided by (used in) investing activities    
Capital expenditures (39) (63)
Proceeds from the sale of (purchases of) debt securities, net 0 0
Change in restricted cash   0
Funds remitted to unconsolidated affiliates 0 0
Proceeds from sale of assets 9 2
Capital contribution to subsidiary (15)  
Proceeds from sale of business, net of cash transferred   173
Return of capital from subsidiary   47
Return of capital from subsidiary from sales of accounts receivable 65 52
Net cash (used in) provided by investing activities 20 211
Cash flows (used in) provided by financing activities    
Net short-term debt (repayments) borrowings 0 (9)
Borrowings of long-term debt 0 164
Repayments of long-term debt (276) (177)
Repayment of advance from affiliates (7)  
Net Intercompany Loan Borrowings (Repayments) 258 (77)
Capital contribution from parent 16  
Long-term debt and credit facility financing fees (2) (1)
Common stock dividends paid (2) (1)
Return of capital to parent   0
Return of capital to parent from sales of accounts receivable 0 0
Net cash used in financing activities (13) (101)
Effect of exchange rates on cash and cash equivalents 0 0
Decrease in cash and cash equivalents 9 14
Cash and cash equivalents (unrestricted) at beginning of period 221 56
Cash and cash equivalents (unrestricted) at end of period 230 70
Subsidiary Issuers [Member]
   
Net cash provided by (used in) operating activities (66) 1
Cash flows provided by (used in) investing activities    
Capital expenditures 0 0
Proceeds from the sale of (purchases of) debt securities, net 0 0
Change in restricted cash   0
Funds remitted to unconsolidated affiliates 0 0
Proceeds from sale of assets 0 0
Capital contribution to subsidiary 0  
Proceeds from sale of business, net of cash transferred   0
Return of capital from subsidiary   0
Return of capital from subsidiary from sales of accounts receivable 0 0
Net cash (used in) provided by investing activities 0 0
Cash flows (used in) provided by financing activities    
Net short-term debt (repayments) borrowings 0 0
Borrowings of long-term debt 450 0
Repayments of long-term debt 0 0
Repayment of advance from affiliates 0  
Net Intercompany Loan Borrowings (Repayments) (364) 4
Capital contribution from parent 0  
Long-term debt and credit facility financing fees (11) 0
Common stock dividends paid (9) (5)
Return of capital to parent   0
Return of capital to parent from sales of accounts receivable 0 0
Net cash used in financing activities 66 (1)
Effect of exchange rates on cash and cash equivalents 0 0
Decrease in cash and cash equivalents 0 0
Cash and cash equivalents (unrestricted) at beginning of period 0 0
Cash and cash equivalents (unrestricted) at end of period 0 0
Combined Subsidiary Guarantors [Member]
   
Net cash provided by (used in) operating activities 16 10
Cash flows provided by (used in) investing activities    
Capital expenditures 0 0
Proceeds from the sale of (purchases of) debt securities, net 0 0
Change in restricted cash   0
Funds remitted to unconsolidated affiliates 0 (1)
Proceeds from sale of assets 0 0
Capital contribution to subsidiary (10)  
Proceeds from sale of business, net of cash transferred   0
Return of capital from subsidiary   0
Return of capital from subsidiary from sales of accounts receivable 0 0
Net cash (used in) provided by investing activities (10) (1)
Cash flows (used in) provided by financing activities    
Net short-term debt (repayments) borrowings 0 0
Borrowings of long-term debt 0 0
Repayments of long-term debt 0 0
Repayment of advance from affiliates 0  
Net Intercompany Loan Borrowings (Repayments) (3) 0
Capital contribution from parent 10  
Long-term debt and credit facility financing fees 0 0
Common stock dividends paid (13) (9)
Return of capital to parent   0
Return of capital to parent from sales of accounts receivable 0 0
Net cash used in financing activities (6) (9)
Effect of exchange rates on cash and cash equivalents 0 0
Decrease in cash and cash equivalents 0 0
Cash and cash equivalents (unrestricted) at beginning of period 0 0
Cash and cash equivalents (unrestricted) at end of period 0 0
Combined Non-Guarantor Subsidiaries [Member]
   
Net cash provided by (used in) operating activities 97 73
Cash flows provided by (used in) investing activities    
Capital expenditures (53) (46)
Proceeds from the sale of (purchases of) debt securities, net 2 (3)
Change in restricted cash   3
Funds remitted to unconsolidated affiliates (1) (4)
Proceeds from sale of assets 1 1
Capital contribution to subsidiary 0  
Proceeds from sale of business, net of cash transferred   0
Return of capital from subsidiary   0
Return of capital from subsidiary from sales of accounts receivable 0 0
Net cash (used in) provided by investing activities (51) (49)
Cash flows (used in) provided by financing activities    
Net short-term debt (repayments) borrowings (7) 20
Borrowings of long-term debt 1 291
Repayments of long-term debt (203) (330)
Repayment of advance from affiliates 0  
Net Intercompany Loan Borrowings (Repayments) 109 73
Capital contribution from parent 15  
Long-term debt and credit facility financing fees 0 0
Common stock dividends paid 0 (2)
Return of capital to parent   (47)
Return of capital to parent from sales of accounts receivable (65) (52)
Net cash used in financing activities (150) (47)
Effect of exchange rates on cash and cash equivalents 4 (3)
Decrease in cash and cash equivalents (100) (26)
Cash and cash equivalents (unrestricted) at beginning of period 207 124
Cash and cash equivalents (unrestricted) at end of period 107 98
Eliminations [Member]
   
Net cash provided by (used in) operating activities (22) (16)
Cash flows provided by (used in) investing activities    
Capital expenditures 0 0
Proceeds from the sale of (purchases of) debt securities, net 0 0
Change in restricted cash   0
Funds remitted to unconsolidated affiliates 0 0
Proceeds from sale of assets 0 0
Capital contribution to subsidiary 25  
Proceeds from sale of business, net of cash transferred   0
Return of capital from subsidiary   (47)
Return of capital from subsidiary from sales of accounts receivable (65) (52)
Net cash (used in) provided by investing activities (40) (99)
Cash flows (used in) provided by financing activities    
Net short-term debt (repayments) borrowings 0 0
Borrowings of long-term debt 0 0
Repayments of long-term debt 0 0
Repayment of advance from affiliates 0  
Net Intercompany Loan Borrowings (Repayments) 0 0
Capital contribution from parent (25)  
Long-term debt and credit facility financing fees 0 0
Common stock dividends paid 22 16
Return of capital to parent   47
Return of capital to parent from sales of accounts receivable 65 52
Net cash used in financing activities 62 115
Effect of exchange rates on cash and cash equivalents 0 0
Decrease in cash and cash equivalents 0 0
Cash and cash equivalents (unrestricted) at beginning of period 0 0
Cash and cash equivalents (unrestricted) at end of period 0 0
Consolidated [Member]
   
Net cash provided by (used in) operating activities 27 (28)
Cash flows provided by (used in) investing activities    
Capital expenditures (92) (109)
Proceeds from the sale of (purchases of) debt securities, net 2 (3)
Change in restricted cash   3
Funds remitted to unconsolidated affiliates (1) (5)
Proceeds from sale of assets 10 3
Capital contribution to subsidiary 0  
Proceeds from sale of business, net of cash transferred   173
Return of capital from subsidiary   0
Return of capital from subsidiary from sales of accounts receivable 0 0
Net cash (used in) provided by investing activities (81) 62
Cash flows (used in) provided by financing activities    
Net short-term debt (repayments) borrowings (7) 11
Borrowings of long-term debt 451 455
Repayments of long-term debt (479) (507)
Repayment of advance from affiliates (7)  
Net Intercompany Loan Borrowings (Repayments) 0 0
Capital contribution from parent 16  
Long-term debt and credit facility financing fees (13) (1)
Common stock dividends paid (2) (1)
Return of capital to parent   0
Return of capital to parent from sales of accounts receivable 0 0
Net cash used in financing activities (41) (43)
Effect of exchange rates on cash and cash equivalents 4 (3)
Decrease in cash and cash equivalents (91) (12)
Cash and cash equivalents (unrestricted) at beginning of period 428 180
Cash and cash equivalents (unrestricted) at end of period $ 337 $ 168